Haesun Choi, M.D.

Peer-Reviewed Articles

1. Boss MA, Snyder BS, Kim E, Flamini D, Englander S, Sundaram KM, Gumpeni N, Palmer SL, Choi H, Froemming AT, Persigehl T, Davenport MS, Malyarenko D, Chenevert TL, Rosen MA. Repeatability and reproducibility assessment of the apparent diffusion Coefficient in the prostate: A trial of the ECOG-ACRIN research group (ACRIN 6701). J Magn Reson Imaging 56(3):668-679, 2022. e-Pub 2022. PMID: 35143059.
2. Altok M, Demirel C, Kang HC, Choi H, John D, Inguillo IA, Davis JW, Ward JF. Impact of MRI/US fusion-guided prostate biopsy on biopsy-naïve patients: A single urologist's experience. BJUI Compass 3(1):19-25, 2022. e-Pub 2021. PMID: 35475153.
3. Tang C, Msaouel P, Hara K, Choi H, Le V, Shah AY, Wang J, Jonasch E, Choi S, Nguyen QN, Das P, Prajapati S, Yu Z, Khan K, Powell S, Murthy R, Sircar K, Tannir NM. Definitive radiotherapy in lieu of systemic therapy for oligometastatic renal cell carcinoma: a single-arm, single-centre, feasibility, phase 2 trial. Lancet Oncol 22(12):1732-1739, 2021. e-Pub 2021. PMID: 34717797.
4. Gregg JR, Borregales LD, Choi H, Lozano M, McRae SE, Venkatesan AM, Davis JW, Nogueras-Gonzalez GM, Pisters LL, Ward JF. Prospective trial of regional (hockey-stick) prostate cryoablation: oncologic and quality of life outcomes. World J Urol 39(WJUR-D-20-01446R2):3259-3264, 2021. e-Pub 2021. PMID: 33454813.
5. Urkmez A, Ward JF, Choi H, Troncoso P, Inguillo I, Gregg JR, Altok M, Demirel HC, Qiao W, Kang HC. Temporal learning curve of a multidisciplinary team for magnetic resonance imaging/transrectal ultrasonography fusion prostate biopsy. BJU Int 127(5):524-527, 2021. e-Pub 2021. PMID: 33340435.
6. Kang HC, Jo N, Bamashmos AS, Ahmed M, Sun J, Ward JF, Choi H. Accuracy of prostate magnetic resonance imaging: reader experience matters. Eur Urol Open Sci 27:53-60, 2021. e-Pub 2021. PMID: 33899028.
7. Shapiro DD, Gregg JR, Lim AH, Nogueras-González GM, Choi H, Kang HC, Inguillo IA, Chapin BF, Davis JW, Ward JF. Comparing confirmatory biopsy outcomes between MRI-targeted biopsy and standard systematic biopsy among men being enrolled in prostate cancer active surveillance. BJU Int 127(3):340-348, 2021. e-Pub 2020. PMID: 32357283.
8. Gupta S, Kang HC, Sun J, Matrana MR, Tannir NM, Choi H. Tumor response criteria for assessing pazopanib first-line therapy in patients with metastatic renal cell carcinoma (mRCC). Abdom Radiol (NY) 45(6):1872-1882, 2020. e-Pub 2019. PMID: 31822966.
9. Mazard T, Boonsirikamchai P, Overman MJ, Asran MA, Choi H, Herron D, Eng C, Maru DM, Ychou M, Vauthey JN, Loyer EM, Kopetz S. Comparison of early radiological predictors of outcome in patients with colorectal cancer with unresectable hepatic metastases treated with bevacizumab. Gut 67(6):1095-1102, 2018. e-Pub 2017. PMID: 29084828.
10. Demireal C, Altok M, Kang H, Choi H, Andres J, Familar E, Davis J, Ward J. MRI-TRUS fusion prostate biopsies: learning curve experience with a multidisciplinary team approach. J Urol 199(45):e525-E526, 2018.
11. Frank SJ, Pugh TJ, Blanchard P, Mahmood U, Graber WJ, Kudchadker RJ, Davis JW, Kim J, Choi H, Troncoso P, Kuban DA, Choi S, McGuire S, Hoffman KE, Chen HC, Wang X, Swanson DA. Prospective phase 2 trial of permanent seed implantation prostate brachytherapy for intermediate-risk localized prostate cancer: Efficacy, toxicity, and quality of life outcomes. Int J Radiat Oncol Biol Phys 100(2):374-382, 2018. e-Pub 2017. PMID: 29229325.
12. Kang HC, Gupta S, Wei W, Lu L, Matrana MR, Tannir NM, Choi H. Alternative response criteria and clinical risk factors for assessing tumor response in patients with metastatic renal cell carcinoma who are receiving salvage therapy. AJR Am J Roentgenol 209(6):1-7, 2017. e-Pub 2017. PMID: 29064751.
13. Clarke CN, Choi H, Hou P, Davis CH, Ma J, Rashid A, Vauthey JN, Aloia TA. Using MRI to non-invasively and accurately quantify preoperative hepatic steatosis. HPB (Oxford) 19(8):706-712, 2017. e-Pub 2017. PMID: 28528267.
14. Farag S, Somaiah N, Choi H, Heeres B, Wang WL, van Boven H, Nederlof P, Benjamin R, van der Graaf W, Grunhagen D, Boonstra PA, Reyners AK, Gelderblom H, Steeghs N. Clinical characteristics and treatment outcome in a large multicentre observational cohort of PDGFRA exon 18 mutated gastrointestinal stromal tumour patients. Eur J Cancer 76:76-83, 2017. e-Pub 2017. PMID: 28284172.
15. Choi H. Role of imaging in response assessment and individualised treatment for sarcomas. Clin Oncol (R Coll Radiol), 2017. e-Pub 2017. PMID: 28506521.
16. Hunter LA, Chen YP, Zhang L, Matney JE, Choi H, Kry SF, Martel MK, Stingo F, Liao Z, Gomez D, Yang J, Court LE. NSCLC tumor shrinkage prediction using quantitative image features. Comput Med Imaging Graph 49:29-36, 2016. e-Pub 2015. PMID: 26878137.
17. Atri M, Zhang Z, Marques H, Gorelick J, Harisinghani M, Sohaib A, Koh DM, Raman S, Gee M, Choi H, Landrum L, Mannel R, Chuang L, Yu JQ, McCourt CK, Gold M. Utility of preoperative ferumoxtran-10 MRI to evaluate retroperitoneal lymph node metastasis in advanced cervical cancer: results of ACRIN 6671/GOG 0233. European J Radiol Open 2:11-18, 2015. PMID: 25774381.
18. Wang J, Kudchadker R, Choi S, Pettaway CA, Choi H, Hobbs BD, Occena MC, McGuire SE, Pugh TJ, Hoffman K, Mahmood U, Kuban DA. Local recurrence map to guide target volume delineation after radical prostatectomy. Pract Radiat Oncol 4(6):e239-46, 2014. e-Pub 2014. PMID: 25407875.
19. Choi H, Underwood M, Boonsirikamchai P, Matin S, Troncoso P, Ma J. Technical challenges in 3 T magnetic resonance spectroscopic imaging of the prostate-A single-institution experience. Quant Imaging Med Surg 4(4):251-8, 2014. PMID: 25202660.
20. Rauch GM, Kaur H, Choi H, Ernst RD, Klopp AH, Boonsirikamchai P, Westin SN, Marcal LP. Optimization of MR imaging for pretreatment evaluation of patients with endometrial and cervical cancer. Radiographics 34(4):1082-98, 2014. PMID: 25019443.
21. Hunter LA, Krafft S, Stingo F, Choi H, Martel MK, Kry SF, Court LE. High quality machine-robust image features: identification in non-small cell lung cancer computed tomography images. Med Phys 40(12):121916, 2013. PMID: 24320527.
22. Peungjesada S, Aloia TA, Kaur H, Marcal L, Choi H, Vauthey JN, Loyer EM. Intrabiliary growth of colorectal liver metastasis: spectrum of imaging findings and implications for surgical management. AJR Am J Roentgenol 201(4):W582-9, 2013. PMID: 24059396.
23. Boonsirikamchai P, Choi S, Frank SJ, Ma J, Elsayes KM, Kaur H, Choi H. MR imaging of prostate cancer in radiation oncology: what radiologists need to know. Radiographics 33(3):741-61, 2013. PMID: 23674772.
24. Peungjesada S, Chuang HH, Prasad SR, Choi H, Loyer EM, Bronstein Y. Evaluation of cancer treatment in the abdomen: trends and advances. World J Radiol 5(3):126-42, 2013. PMID: 23671749.
25. Chen LL, Chen X, Choi H, Sang H, Chen LC, Zhang H, Gouw L, Andtbacka RH, Chan BK, Rodesch CK, Jimenez A, Cano P, Jones KA, Oyedeji CO, Martins T, Hill HR, Schumacher J, Willmore C, Scaife CL, Ward JH, Morton K, Lor Randall R, Lazar AJ, Patel S, Trent JC, Frazier ML, Lin P, Jensen P, Benjamin RS. Exploiting antitumor immunity to overcome relapse and improve remission duration. Cancer Immunol Immunother 61(7):1113-24, 2012. e-Pub 2011. PMID: 22198309.
26. Boonsirikamchai P, Kaur H, Kuban DA, Jackson E, Hou P, Choi H. Use of maximum slope images generated from dynamic contrast-enhanced magnetic resonance imaging to detect locally recurrent prostate carcinoma following prostatectomy - a practical approach. AJR Am J Roentgenol 198(3):W228-236, 2012. PMID: 22358019.
27. Kaur H, Choi H, You YN, Rauch GM, Jensen CT, Hou P, Chang GJ, Skibber JM, Ernst RD. MR imaging for preoperative evaluation of primary rectal cancer: practical considerations. Radiographics 32(2):389-409, 2012. PMID: 22411939.
28. Asran MK, Loyer EM, Kaur H, Choi H. Case 177: congenital absence of the portal vein with hepatic adenomatosis. Radiology 262(1):364-7, 2012. PMID: 22190661.
29. Hou P, Popat UR, Lindsay RJ, Jackson EF, Choi H. A practical approach for a wide range of liver iron quantitation using a magnetic resonance imaging technique. Radiol Res Pract 2012:207391, 2012. e-Pub 2012. PMID: 23365743.
30. Katz D, Boonsirikamchai P, Choi H, Lazar AJ, Wang WL, Xiao L, Park MS, Ravi V, Benjamin RS, Araujo DM. Efficacy of first-line doxorubicin and ifosfamide in myxoid liposarcoma. Clin Sarcoma Res 2(1):2, 2012. e-Pub 2012. PMID: 22587772.
31. Choi H. Imaging modalities of gastrointestinal stromal tumors. J Surg Oncol 104(8):907-914, 2011. PMID: 22069176.
32. Park MS, Patel SR, Ludwig JA, Trent JC, Conrad CA, Lazar AJ, Wang WL, Boonsirikamchai P, Choi H, Wang X, Benjamin RS, Araujo DM. Activity of Temozolomide and Bevacizumab in the treatment of locally advanced recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor. Cancer 117(21):4939-47, 2011. e-Pub 2011. PMID: 21480200.
33. Oh JY, Cho JH, Kang MJ, Lee JH, Kwon HJ, Nam KJ, Kim MC, Choi H. Omental infarction caused by laparoscopy-assisted gastrectomy for gastric cancer: CT findings. Clin Radiol 66(10):966-973, 2011. PMID: 21684534.
34. Asran MK, Loyer EM, Kaur H, Choi H. Case 177. Radiology 260(3):908-910, 2011.
35. Kaur H, Matin SF, Javadi S, Johnson VE, Choi H, Sandler C, Ahrar K. Chyluria after radiofrequency ablation of renal tumors. J Vasc Interv Radiol 22(7):924-7, 2011. e-Pub 2011. PMID: 21507680.
36. Boonsirikamchai P, Loyer EM, Choi H, Charnsangavej C. Planning and follow-up after ablation of hepatic tumors: imaging evaluation. Surg Oncol Clin N Am 20(2):301-315, 2011. e-Pub 2010. PMID: 21377585.
37. Mohamed AA, Kaur H, Loyer E, Choi H. Diagnosis please: part 1. Radiology 260(3):908-910, 2011.
38. Marcal L, Nothaft MA, Coelho F, Choi H. Deep pelvic endometriosis: MR imaging. Abdom Imaging 35(6):708-715, 2010. e-Pub 2010. PMID: 20390267.
39. McAuliffe JC, Hunt KK, Lazar AJ, Choi H, Qiao W, Thall P, Pollock RE, Benjamin RS, Trent JC. A randomized, phase II study of preoperative plus postoperative Imatinib in GIST: evidence of rapid radiographic response and temporal induction of tumor cell apoptosis. Ann Surg Oncol 16(4):910-919, 2009. e-Pub 2008. PMID: 18953611.
40. Boonsirikamchai P, Podoloff DA, Choi H. Imaging of gastrointestinal stromal tumors and assessment of benefit from systemic therapy. Hematol Oncol Clin North Am 23(1):35-48, 2009. PMID: 19248969.
41. Weinreb J C, Blume D, Coakley F V, Wheeler T M, Cormack J B, Sotto C K, Choi H, Kawashima A, Tempany-Afdahl C M, Macura K J, Rosen M, Gerst S R, Kurhanewicz J. Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic study. Radiology 251(1):122-133, 2009.
42. Bhosale P, Ma J, Choi H. Utility of the FIESTA pulse sequence in body oncologic imaging: review. AJR Am J Roentgenol 192(6 Suppl):S83-S93, 2009. PMID: 19458102.
43. Bhosale P, Ma J, Choi H. Utility of the FIESTA pulse sequence in body oncologic imaging: self-assessment module. AJR Am J Roentgenol 192:S94-S97, 2009.
44. Kleinbaum EP, Lazar AJ, Tamborini E, Mcauliffe JC, Sylvestre PB, Sunnenberg TD, Strong L, Chen LL, Choi H, Benjamin RS, Zhang W, Trent JC. Clinical, histopathologic, molecular and therapeutic findings in a large kindred with gastrointestinal stromal tumor. Int J Cancer 122(3):711-718, 2008. PMID: 17943734.
45. Choi H. Response evaluation of gastrointestinal stromal tumors. Oncologist 13 Suppl 2:4-7, 2008. PMID: 18434631.
46. Choi H, Ma J. Use of perfluorocarbon compound in the endorectal coil to improve MR spectroscopy of the prostate. AJR Am J Roentgenol 190(4):1055-1059, 2008. PMID: 18356455.
47. Chen LL, Holden JA, Choi H, Zhu J, Wu EF, Jones KA, Ward JH, Andtbacka RH, Randall RL, Scaife CL, Hunt KK, Prieto VG, Raymond AK, Zhang W, Trent JC, Benjamin RS, Frazier ML. Evolution from heterozygous to homozygous KIT mutation in gastrointestinal stromal tumor correlates with the mechanism of mitotic nondisjunction and significant tumor progression. Mod Pathol 21(7):826-836, 2008. PMID: 18488000.
48. Choi H, Charnsangavej C, Faria SC, Macapinlac HA, Burgess MA, Patel SR, Chen LL, Podoloff DA, Benjamin RS. Correlation of computed tomography (CT) and positron emission tomography (PET) in patients with metastatic GIST treated at a single institution with imatinib mesylate: proposal of new CT response criteria. J Clin Oncol 25(13):1753-1759, 2007. PMID: 17470865.
49. Benjamin RS, Choi H, Macapinlac HA, Burgess MA, Patel SR, Chen LL, Podoloff DA, Charnsangavej C. We should desist using RECIST, at least in GIST. J Clin Oncol 25(13):1760-1764, 2007. PMID: 17470866.
50. Li C, Liengsawangwong R, Choi H, Cheung R. Using a prior structural information from magnetic resonance imaging to investigate the feasibility of prostate diffuse optical tomography and spectroscopy: a simulation study. Med Phys 34(1):266-274, 2007. PMID: 17278512.
51. Ma J, Son JB, Zou Y, Le-Petross H, Choi H. Fast spin echo triple echo Dixon (fTED) technique for efficient T2-weighted water and fat imaging. Magn Reson Med 58(1):103-109, 2007. PMID: 17659631.
52. Kundra V, Silverman PM, Matin M, Choi H. Imaging in oncology from the University of Texas MD Anderson Cancer Center: diagnosis, staging, and surveillance of prostate cancer. AJR Am J Roentgenol 189(4):830-844, 2007. PMID: 17885053.
53. Demetri GD, Benjamin RS, Blanke CD, Blay JY, Casali P, Choi H, Corless CL, Debiec-Rychter M, DeMatteo RP, Ettinger DS, Fisher GA, Fletcher CD, Gronchi A, Hohenberger P, Hughes M, Joensuu H, Judson I, Le Cesne A, Maki RG, Morse M, Pappo AS, Pisters PW, Raut CP, Reichardt P, Tyler DS, Van den Abbeele AD, von Mehren M, Wayne JD, Zalcberg J, Zalcberg J. NCCN task force report: management of patients with gastrointestinal stromal tumor (GIST) - update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw 5 Suppl 2:S1-29; quiz S30, 2007. PMID: 17624289.
54. Chirieac LR, Trent JC, Steinert DM, Choi H, Yang Y, Zhang J, Patel SR, Benjamin RS, Raymond AK. Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylate. Cancer 107(9):2237-2244, 2006. PMID: 16998931.
55. Steinert DM, Oyarzo M, Wang X, Choi H, Thall PF, Medeiros LJ, Raymond AK, Benjamin RS, Zhang W, Trent JC. Expression of Bcl-2 in gastrointestinal stromal tumors: correlation with progression-free survival in 81 patients treated with imatinib mesylate. Cancer 106(7):1617-1623, 2006. PMID: 16518826.
56. Hong X, Choi H, Loyer EM, Benjamin RS, Trent JC, Charnsangavej C. Gastrointestinal stromal tumor: role of CT in diagnosis and in response evaluation and surveillance after treatment with imatinib1. Radiographics 26(2):481-495, 2006. PMID: 16549611.
57. Ma J, Vu AT, Son JB, Choi H, Hazle JD. Fat-suppressed three-dimensional dual echo Dixon technique for contrast agent enhanced MRI. J Magn Reson Imaging 23(1):36-41, 2006. PMID: 16315212.
58. Kwek JW, Choi H, Ma J, Miller MJ. Gel-gel double-lumen silicone breast implant: mimic of intracapsular implant rupture. AJR Am J Roentgenol 187(4):W436-W437, 2006. PMID: 16985119.
59. Blay JY, Bonvalot S, Casali P, Choi H, Debiec-Richter M, Dei Tos AP, Emile JF, Gronchi A, Hogendoorn PCW, Joensuu H, Le Cesne A, MacClure J, Maurel J, Nupponen N, Ray-Coquard I, Reichardt P, Sciot R, Stroobants S, van Glabbeke M, van Oosterom A, Demetri GD. Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO. Ann Oncol 16(4):566-578, 2005. PMID: 15781488.
60. Chen LL, Sabripour M, Andtbacka RH, Patel SR, Feig BW, Macapinlac HA, Choi H, Wu EF, Frazier ML, Benjamin RS. Imatinib resistance in gastrointestinal stromal tumors. Curr Oncol Rep 7(4):293-299, 2005. PMID: 15946589.
61. Kavanagh JJ, Gershenson DM, Choi H, Lewis L, Patel K, Brown GL, Garcia A, Spriggs DR. Multi-institutional phase 2 study of TLK286 (TELCYTA, a glutathione S-transferase P1-1 activated glutathione analog prodrug) in patients with platinum and paclitaxel refractory or resistant ovarian cancer. Int J Gynecol Cancer 15(4):593-600, 2005. PMID: 16014111.
62. Lee CT, Dong L, Ahamad AW, Choi H, Cheung R, Lee AK, Horne DF, Breaux AJ, Kuban DA. Comparison of treatment volumes and techniques in prostate cancer radiation therapy. Am J Clin Oncol 28(6):618-625, 2005. PMID: 16317275.
63. Ma J, Son JB, Bankson JA, Stafford RJ, Choi H, Ragan D. A fast spin echo two-point Dixon technique and its combination with sensitivity encoding for efficient T2-weighted imaging. Magn Reson Imaging 23(10):977-982, 2005. PMID: 16376180.
64. Chen LL, Trent JC, Wu EF, Fuller GN, Ramdas L, Zhang W, Raymond AK, Prieto VG, Oyedeji CO, Hunt KK, Pollock RE, Feig BW, Hayes KJ, Choi H, Macapinlac HA, Hittelman W, Velasco MA, Patel S, Burgess MA, Benjamin RS, Frazier ML. A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors. Cancer Res 64(17):5913-5919, 2004. PMID: 15342366.
65. Ma J, Choi H, Stafford RJ, Miller MJ. Silicone-specific imaging using an inversion-recovery-prepared fast three-point Dixon technique. J Magn Reson Imaging 19(3):298-302, 2004. PMID: 14994297.
66. Bronstein YL, Loyer EM, Kaur H, Choi H, David C, DuBrow RA, Broemeling LD, Cleary KR, Charnsangavej C. Detection of small pancreatic tumors with multiphasic helical CT. AJR Am J Roentgenol 182(3):619-623, 2004. PMID: 14975959.
67. Choi H, Charnsangavej C, de Castro Faria S, Tamm EP, Benjamin RS, Johnson MM, Macapinlac HA, Podoloff DA. CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings. AJR Am J Roentgenol 183(6):1619-1628, 2004. PMID: 15547201.
68. Choi H, David CL, Katz RL, Podoloff DA. Diagnosis please case 69: extramedullary hematopoiesis. Radiology 231(1):52-56, 2004. PMID: 14990806.
69. Curley SA, Marra P, Beaty K, Ellis LM, Vauthey JN, Abdalla EK, Scaife C, Raut C, Wolff R, Choi H, Loyer E, Vallone P, Fiore F, Scordino F, De Rosa V, Orlando R, Pignata S, Daniele B, Izzo F. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg 239(4):450-458, 2004. PMID: 15024305.
70. Demetri GD, Benjamin R, Blanke CD, Choi H, Corless C, DeMatteo RP, Eisenberg BL, Fletcher CDM, Maki RG, Rubin B, Van den Abbeele AD, von Mehren M. NCCN task force report: optimal management of patients with gastrointestinal stromal tumors (GIST) – expansion and update of NCCN Clinical Practice Guidelines. J Natl Compr Canc Netw 2(Suppl 1), 2004.
71. Choi H, David CL, Katz RL, Podoloff D. Case 69. Radiology 229(3):724-725, 2003.
72. Szklaruk J, Tamm EP, Choi H, Varavithya V. MR imaging of common and uncommon large pelvic masses. Radiographics 23(2):403-424, 2003. PMID: 12640156.
73. Choi H, Whitman G, Ro J, Charnsangavej C. Benign schwannoma in the porta hepatis. AJR Am J Roentgenol 177:652, 2001. PMID: 11517064.
74. Choi H, Loyer E, Dubrow R, Kaur H, David C, Huang S, Curley S, Charnsangavej C. Radio-frequency ablation of liver tumors: assessment of therapeutic response and complications. Radiographics 21 Spec No:S41-S54, 2001. PMID: 11598247.
75. Charnsangavej C, Loyer EM, Iyer RB, Choi H, Kaur H. Tumors of the liver, bile duct, and pancreas. Curr Probl Diagn Radiol 29(3):69-107, 2000. PMID: 10875047.
76. Netscher D, Mosharrafa A, Lee M, Polsen C, Choi H, Steadman AK, Thornby J. Transverse carpal ligament: its effect on flexor tendon excursion, morphologic changes of the carpal canal, and on pinch and grip strengths after open carpal tunnel release. Plast Reconstr Surg 100(3):636-642, 1997. PMID: 9283561.
77. Netcher D, Polsen C, Thornby J, Choi H, Udeh J. Anatomic delineation of the ulnar nerve and ulnar artery in relation to the carpal tunnel by axial magnetic resonance imaging scanning. J Hand Surg 21(2):273-276, 1996.
78. Choi H, Varma DG, Fornage BD, Kim EE, Johnston DA. Soft-tissue sarcoma: MR imaging vs sonography for detection of local recurrence after surgery. AJR Am J Roentgenol 157(2):353-358, 1991. PMID: 1853821.
79. Choi H, Karim R, Bruch P, Boyd S, Marcus M, Kirchner PT. Quantitation of Thallium 201 kinetics after dipyridamole in normal volunteers. Am J Card Imaging 3(4):299-307, 1989.
80. Choi H, Choi IY, Chung HS. A case of lymphoblastic lymphoma. Korean J Hematol 17:79, 1982.
81. Choi H, Sohn LJ, Lee DH, Sohn ES. Clinical observation on antihypertensive effects of Atenolol (Tenormin). J Korean Am Med Assoc 24:818, 1982.
82. Lee DH, Choi H, Kim SK, Hahn SW, Park KS, Park KN. Ultrasonographic demonstration of intestinal obstruction. Korean Soc Med Ultrasound 1:17, 1982.
83. Park YK, Choi H, Lee YK, Lee BH, Lee DH, Kee CS, Park KN. Serum gastrin analysis of the patients with peptic ulcer disease and stomach cancer. Korean J Intern Med 25:1, 1982.
84. Sohn ES, Lee DH, Lee BH, Choi H. Cardiovascular disease and its risk factors in Korea. Jpn Circ J 46:601, 1982.
85. Seok SE, Park CH, Nam SH, Choi H, Lee JI, Lee DH, Huh BY, Sohn ES. An experimental study on the antihypertensive effect of Korean ginseng to spontaneously hypertensive rats (SHR) in labile stage of hypertension. J Korean Am Med Assoc 24:509, 1981.

Invited Articles

1. Choi H. Critical issues in response evaluation on computed tomography: lessons from the gastrointestinal stromal tumor model. Curr Oncol Rep 7(4):307-311, 2005. PMID: 15946591.
2. Choi H, Loyer EM, Charnsangaveg C. Neoplasms of the liver and bile ducts. Semin Roentgenol 39(3):412-427, 2004. PMID: 15372754.
3. Faria SC, Tamm EP, Loyer EM, Szklaruk J, Choi H, Charnsangavej C. Diagnosis and staging of the pancreatic tumors. Semin Roentgenol 39(3):397-411, 2004. PMID: 15372753.

Manuals, Teaching Aids, Other Teaching Publications

1. Choi H. Body MRI Protocol Manual (1.5T and 3T). The University of Texas MD Anderson Cancer Center: Houston, TX, 2012.
2. Choi H. Body MRI Protocol Manual (1.5T). The University of Texas MD Anderson Cancer Center: Houston, TX, 2008.
3. Choi H. Body MRI Protocol Manual (1.5T and 3T). The University of Texas MD Anderson Cancer Center: Houston, TX, 2007.
4. Choi H. The Era of Molecular Therapy: Redefining the Treatment of Gastrointestinal Stromal Tumors (GIST). Update. Health Science Center for CME: New York, NY, 2006.
5. Choi H. The Era of Molecular Therapy: Redefining the Treatment of Gastrointestinal Stromal Tumors (GIST). Health Science Center for CME: New York, NY, 2005.
6. Choi H. Body MRI Protocol Manual (1.5T and 3T). The University of MD Anderson Cancer Center: Houston, TX, 2004.
7. Choi H. Radiology Procedure Manual. VA Medical Center: Houston, TX, 1999.
8. Choi H. MRI Procedure Manual. VA Medical Center: Houston, TX, 1991.

Other Articles

1. Nagle CE From The Literature "Choi Criteria vs. RECIST in GIST". J Nucl Med 48(7):40N, 2007.

Abstracts

1. Pieretti A, Kang H, Choi H, Zhang M, Chapin B, Ward J, Troncoso P, Gregg J. Using magnetic resonance imaging to define focal therapy templates in patients with intermediate-risk prostate cancer. J Urol 207(Supplment 5):E937, 2022.
2. Kennady EH, Kang H, Choi H, Akorede A, Davis JW, Pisters L, Pettaway C, Chapin BF, Ward JF, Gregg JR. Determining clinical outcomes among men with a high-risk prostate MRI and negative fusion biopsy. Society of Urologic Oncology 22nd Annual Meeting, 2021.
3. Borregales L, Gregg J, Choi H, Lozano M, McRae SE, Venkatesan AM, Gonzalez GN, Davis J, Pisters L, Ward J. Prospective trial of regional (hockey-stick) prostate cryoablation: oncologic and quality of life outcomes. J Urol 203(Suppl 4):E1060, 2020.
4. Jo N, Vining DJ, Choi H. Improving communication between radiologists, pathologists, and urologists by using a PI-RADS structured reporting system. 105th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2019.
5. Son JB, Shin S, Noeske R, Bayram E, Ma J, Choi H. Prostate MRSI with reduced acquisition time and improved multichannel spectral processing. Proceedings of the ISMRM 24th Annual Meeting and Exhibition, 2016.
6. Farag S, Somaiah N, Choi H, Heeres B, Wang WL, Van Boven H, Nederlog PM, Benjamin RS, van der Graaf WTA, Grunhagen DJ, Boonstra P, Reyners AKL, Gelderblom H, Steeghs N. Clinical characteristics and treatment outcome in a large multicenter observational cohort of pdgfra exon 18 mutated gastrointestinal stromal tumor (GIST) patients. JCO 34(15_suppl):11011, 2016.
7. Lindsay R, Saliba RM, Choi H, Ping H, Ramlal R, Alousi A, Jones R, Champlin R, Popat U. Transfusion history is the most significant predictor of iron overload after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 22(3):S336-S337, 2016.
8. Kaur H, Taggart MW, Shin S, Ernst RD, Loyer EM, Aloia TA, Sharma R, Choi H. Atypical imaging presentations of focal nodular hyperplasia with radiologic pathologic correlation. 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2013.
9. Hunter L, Chen Y, Zhang L, Matney J, Stingo F, Kry S, Martel M, Choi H, Liao Z, Gomez D, Court L. TU-A-WAB-11: Tumor shrinkage prediction using CT image features. Med Phys 40(6):424-425, 2013.
10. Hunter L, Stingo F, Kry S, Martel M, Choi H, Court L. WE-G-500-01: Identification of high quality machine-robust CT image features. Med Phys 40(6):503, 2013.
11. Sabir SH, McRae SE, Ward JF, Choi H, Wallace MJ. Transgluteal MR-guided prostate biopsy: results of a freehand technique in a closed 1.5T MRI. Journal of Vascular and Interventional Radiology, 2013.
12. Aloia TA, Zimmitti G, Ma J, Hou P, Rashid A, Curley SA, Vauthey J, Choi H. Non-Invasive preoperative quantification of hepatic steatosis using a novel MRI technique: 100% accuracy confirmed with pathologic assessment. Special Issue: Abstracts of the Thirteenth Annual Americas Hepato-Pancreato-Biliary Congress 2013 15(S1):2, 2013.
13. Kaur H, Uribe E, Choi H, Loyer EM. Strengths and limitations of extravascular and liver specific contrast agents in the evaluation of liver lesions. 98th Scientific Assembly & Annual Meeting of the Radiological Society of North America, 2012.
14. Choi H, Kuban D, Ward J, Kaur H. Clinically relevant personalized prostate imaging: how do we do?. 98th Scientific Assembly & Annual Meeting of the Radiological Society of North America, 2012.
15. Kaur H, Sagebiel TL, You YN, Hou P, Choi H. Preoperative staging of primary rectal tumors: roles of thin section multiplanar 2D T2 FSE imaging, 3D CUBE and diffusion-weighted imaging. 96th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2012.
16. Ernst RD, Kaur H, Rauch GM, Chang GJ, You YN, Choi H, Skibber JM. Key findings in rectal cancer with emphasis on 3 T MRI. 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2011.
17. Rauch GM, Ernst RD, Marcal LP, Choi H, Chang GJ, You YN; et al. Role of the high-resolution MRI in the presurgical evaluation of low rectal tumors. 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2011.
18. Rauch GM, Marcal LP, Ernst RD, Boonsirikamchai P, Klopp A, Choi H, Kaur H. Optimization of high-resolution MRI technique for pretreatment staging of the cervical and endometrial cancer. 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2011.
19. Kaur H, Loyer E, Charnsangavej C, Choi H. New paradigm for response evaluation of solid tumors in the era of targeted therapy: comparison with traditional size-based response criteria. 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2011.
20. Jensen CT, Rauch GM, You YN, Chang GJ, Choi H, Skibber JM, Ernst RD. Mucinous adenocarcinoma of the rectum: disease patterns and pitfalls. 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2011.
21. Kaur H, Thomas A, Jensen C, Bronstein Y, Vauthey JN, Choi H, Loyer E. Biliary invasion in colorectal metastasis: diagnostic criteria on CT and clinical significance. 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2011.
22. Hou P, Popat U, Lindsay R, Jackson E, Choi H. MO-F-211-03: A practical approach for liver iron measurement in clinical setting. Med Phys 38(6):3730, 2011.
23. Gao J, McAuliffe JC, Lazar AJF, Wang W, Choi H, Hunt K, Araujo M, Pollock RE, Benjamin RS, Trent JC. Mechanism of early radiographic response to imatinib in GIST. Journal of Clinical Oncology 29(10049), 2011.
24. Reynoso D, Alicie B, Yang D, Dumont A, Conley A, McAuliffe J, Choi H, Lazar A, Miyashita T, Rubin B, Zhang W, Trent J. BIM upregulation correlates with apoptosis in gastrointestinal stromal tumor patients treated with imatinib. Clinical Cancer Research, 2011.
25. Ernst R, Kaur H, You YN, Rodriguez-Bigas M, Choi H. Structured reporting for MRI staging of rectal cancer. 96th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2010.
26. Choi H, Boonsirikamchai P, Kaur H, Johnson V, Underwood M, Ma J. Factors affecting, and possible ways for improving, the prostate MR spectroscopic quality: a single institution experience, 2008.
27. Park MS, Patel SR, Ludwig JA, Trent JC, Conrad CA, Lazar AJ, Choi H, Benjamine RS, Araujo DM. Combination therapy with temozolomide and bevacizumab in the treatment of hemangiopericytoma/malignant solitary fibrous tumor. J Clin Oncol 26(suppl), 2008.
28. Bhosale P, Choi H, Ma J.. Utility of FIESTA sequence in day to day MRI imaging. 107th Annual Meeting of the American Roentgen Ray Society (#1031), 2007.
29. Benjamin RA, Choi H, Macapinlac HA, Burgess MA, Patel SR, Chen LL, Podoloff DA, Chuslip C. Response of gastrointestinal stromal tumors (GISTs) to imatinib by Choi criteria and response evaluation criteria in solid tumors (RECIST) as surrogates for survival and time to progression. J Clin Oncol, American Society of Clinical Oncology Annual Meeting Proceedings Part I 24(18S), 2006.
30. Tamm E, Szklaruk J, Iyer RB, Choi H, Lano EA, Holmes R.. Online tools for collaboration between radiologists and clinicians in a PACS environment. 90th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2004.
31. Choi H, Zhou X, Ma J. Use of perfluorocarbon in magnetic resonance spectroscopy (MRS) of prostate: a method to improve the linewidth and quality of spectra. 90th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2004.
32. Brown GL, Lewis L, Choi H, Iyer R, Moore C, Valmonte A, Jameson A, Keck J, Patel K, Kavanagh J. Phase 1-2a dose ranging study of TLK286 (a novel glutathione analog) in combination with liposomal doxorubicin in platinum refractory or resistant ovarian cancer. (#5062). J Clin Oncol, American Society of Clinical Oncology Annual Meeting Proceedings (Post-Meeting Edition) 22(14S), 2004.
33. Kavanagh L, Lewis L, Choi H, Iyer R, Moore C, Jameson A, Keck J, Parra R, Patel K, Brown GL. Phase 1-2a study of TLK286 (a novel glutathione analog) in combination with carboplatin in platinum refractory or resistant (3rd line) ovarian cancer. J Clin Oncol, American Society of Clinical Oncology Annual Meeting Proceedings (Post-Meeting Edition) 22(14S), 2004.
34. Marcal L, Choi H, Jackson E, Benjamin RS, Rashid A. Use of quantitative dynamic contrast MR imaging to monitor musculoskeletal sarcomas: correlation with FDG PET and pathology. International Society for Magnetic Resonance in Medicine, 12th Annual Meeting, 2004.
35. Benjamin RS, Choi H, Charnsangavej C, Macapinlac HA, Burgess MA, Chen LL, Trent JC, Patel SR. Should desist using recist, at least in GIST. 8th Annual Meeting, Connective Tissue Oncology Society, 2003.
36. Choi H, Charnsangavej C, Macapinlac HA, Burgess M, Patel S, Chen L, Podoloff D, Benjamin R. Correlation of CT and PET in patients with metastatic GIST treated at a single institution with Imatinib Mesylate. Proc Am Soc Clin Oncol 22, 2003.
37. Ma J, Choi H, Stafford JR. Silicone prosthesis imaging using an inversion recovery fast spin echo and fast Dixon technique. International Society for Magnetic Resonance in Medicine, 11th Annual Meeting, 2003.
38. Ma J, Choi H, Stafford JR. Dynamic study of sarcoma with reduced-encoding imaging by generalized-series reconstruction. International Society for Magnetic Resonance in Medicine, 11th Annual Meeting, 2003.

Book Chapters

1. Choi H. Radiotherapy in practice: imaging in clinical oncology. In: Gastrointestinal Stromal Tumor. 2nd. Oxford University Press, 2021.
2. Choi H. Traditional size-based response evaluation criteria in solid tumors (RECIST) and new evidence based response evaluation criteria (Choi Criteria) in sarcoma. In: Sarcoma Oncology: A Multidisciplinary Approach. 1st. People's Medical Publishing House, 2016.
3. Choi H, Loyer EM, Kaur H, Silverman PM. Imaging neoplasms of the abdomen and pelvis. In: Cancer Medicine 7. B.C. Decker Inc.: Baltimore, 474-478, 2005.
4. Choi H, Loyer EM, Charnsangavej C. Radiographic imaging following radiofrequency ablation of liver tumors. In: Radiofrequency Ablation for Cancer. 1. Springer: New York, NY, 253-267, 2004.
5. Choi H, Loyer EM, Charnsangavej C.. Imaging assessment following radiofrequency ablation of liver tumors. In: Radiofrequency Ablation of Cancer Current Indications, Techniques and Outcomes. Springer: New York, 2003.
6. Choi H, Loyer EM, Kaur H, Silverman PM. Imaging neoplasms of the abdomen and pelvis. In: Cancer Medicine 6. B. C. Decker, Inc.: Baltimore, 523-527, 2003.

Letters to the Editor

1. Choi H, Charnsangavej C, Faria SC, Tamm EP, Benjamin RS, Johnson MM, Macapinlac HA, Podoloff DA. CT Evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings. Letter and Reply. Drs. Choi and Johnson respond. AJR Am J Roentgenol 185: 1366-1367, 2005.